transforming mutation pleckstrin homology domain akt1 cancer
although akt1 v-akt murine thymoma viral oncogene homologue kinase central member possibly frequently activated proliferation survival pathway cancer mutation akt1 widely reported report identification somatic mutation human breast colorectal ovarian cancers results glutamic acid lysine substitution amino acid e17k lipid-binding pocket akt1 lys alters electrostatic interactions pocket forms new hydrogen bonds phosphoinositide ligand mutation activates akt1 means pathological localization plasma membrane stimulates downstream signalling transforms cells induces leukaemia mice mechanism indicates direct role akt1 human cancer adds known genetic alterations promote oncogenesis phosphatidylinositol--oh kinase/akt pathway furthermore e17k substitution decreases sensitivity allosteric kinase inhibitor mutation may important clinical utility akt drug development
